Civitas Therapeutics Announces Positive Phase 2b Results for CVT-301, Inhaled Levodopa for the Treatment of Parkinson’s Disease by longitudeadmin | Apr 28, 2014 | Portfolio News
Practice Fusion Named the No. 1 Electronic Health Records (EHR) Vendor in Primary Care Practices for Fifth Year Running by longitudeadmin | Apr 7, 2014 | Portfolio News
Collegium Pharmaceutical Announces Positive Topline Results of Clinical Study Evaluating the Effect of Crushing Oxycodone DETERx® Compared with OxyContin® by longitudeadmin | Apr 2, 2014 | Portfolio News
US Oncology Research Joins Corcept Therapeutics’ Phase I Breast Cancer Study by longitudeadmin | Apr 2, 2014 | Portfolio News
Jazz Pharmaceuticals And Gentium Announce European Commercial Launch Of First Approved Life-Saving Treatment For Severe Hepatic Veno-Occlusive Disease by longitudeadmin | Mar 31, 2014 | Portfolio News
